News
New research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.
Eight individuals, including employees from Dr Reddy's Lab, have been arrested for stealing Semaglutide powder worth over Rs.
A new study published in The Lancet journal showed that patients with type 2 diabetes and symptomatic peripheral arterial ...
7h
News-Medical.Net on MSNWeight loss drug semaglutide proven safe and effective for people with schizophreniaDiabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...
Blockbuster weight loss drugs like Ozempic, Wegovy and Mounjaro might not work as well as advertised, a bombshell study from ...
Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.
Explore more
Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight ...
17h
News-Medical.Net on MSNReal-world study finds lower weight loss with GLP-1 drugs due to early discontinuationA Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...
Ozempic is a medication primarily approved for managing type 2 diabetes. Its active ingredient, semaglutide, mimics a hormone ...
Canada: A recent observational cohort study from Canada revealed that older diabetic patients taking GLP-1 receptor ...
Diabetic weight loss medications are effective for people with schizophrenia without affecting psychotic symptoms, University ...
A new study published in the Obesity Journal found that anti-obesity injections may have a lesser impact on weight loss in a real-world context compared to clinical trials, as patients tend to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results